News

Prices soar as Europeans buy up potassium iodide pills over nuclear fears

Add Ticker News on Google

The escalating conflict in Europe has led to a surge in demand for potassium iodide pills over fears of a nuclear disaster

There’s been cases of price gouging across the United States and Europe, over fears of radioactive fallout.

After Russia’s recent attack on Europe’s largest nuclear power plant, pharmacies across America and Europe began to notice a surge in demand for potassium iodide.

As Russia continues its assault across Ukraine, and nuclear powers come head to head, for many customers it’s a case of what if.

In such an event, radioactive iodide would enter the atmosphere, which contaminates water, soil, plants and our lungs.

Although potassium iodide isnt harmful, the radioactive variety can harm the thyroid, which produces many of the hormones that regulate the body.

Large manufacturers of potassium iodide tablets have seen their stock rapidly disappear over recent weeks.

And as supplies dry up, prices have soared.

A box that usually sells for $14 is now going for over 100.

The pills dont offer 100% protection against radioactive iodide and America’s CDC warns they only work for certain age groups.

One of America’s top suppliers is directing visitors to its website that it’s sold out.

But this isn’t new. Historically whenever there’s a real or perceived threat of nuclear fallout, demand for potassium iodide soars. The last time was in 2018, when Donald Trump escalated fears of a conflict with North Korea. 

Customers who have bought the pills are being warned to only take them on the direction of health officials.

Up next
Could tax cuts deliver a better deal for hospitality businesses and workers?

Victoria’s hospitality industry is facing growing pressure from rising employment costs, with business operators.

Read the story →

Comments

No comments yet. Start the conversation.

Comments are checked before they appear. Keep it civil, and please don't make claims about people you can't back up.

Ticker Today takes a daily view of the world of news, politics and business.With Ahron YoungWhisky & Suits explores law, property finance and business over fine whisky.With Imran Khan and Chris ChristofiThe Founders Method explores practical lessons and systems for entrepreneursWith Jonathan Byrt and Jesse LeeworthyThe Connector explores property and urban growth across Australia and the UK.With Belinda CoateThe Property Playbook delivers research-led insights for property investors.With Tim Graham and Terry RyderState of Hospitality explores the challenges facing Australia's hospitality.With Jeremy KoadlowBuying Power helps young professionals enter property and build lasting wealth.With Victor and Reshmi KumarThe Airport Economist explores global trade, business and economic outlooks.With Tim HarcourtMedia Movers explores the trends shaping Australia's media and global news.With James ManningBroker Business explores strategies to build, grow and sustain a business.With Rex AfrasiabiMoney Matters explores practical financial strategies to build lasting wealth.With Dr Steven EnticottBeyond Education explores the ideas and technology shaping future learning.With Greg CampitelliTicker Air explores the latest aviation news, travel trends and developments.With Ahron YoungEarly Years Dialogue explores the issues shaping Australia's early learning.With Paul MondoMarkets and Machines explores AI, regulation and trends shaping the markets.With Chris BergSocial Intelligence explores how social media and AI transform our daily lives.With Dr Karen SutherlandThe AI Edge explores how artificial intelligence reshapes the world economy.With Brad Gastwirth

More from Ticker

Watch

More in News

View all →